Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mallinckrodt Plc Ordinary Share (MNK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,315,734
  • Shares Outstanding, K 83,210
  • Annual Sales, $ 3,222 M
  • Annual Income, $ 2,134 M
  • 36-Month Beta 1.60
  • Price/Sales 0.70
  • Price/Cash Flow 1.67
  • Price/Book 0.35

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 1.79
  • Number of Estimates 11
  • High Estimate 1.90
  • Low Estimate 1.65
  • Prior Year 1.97
  • Growth Rate Est. (year over year) -9.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.12 +10.25%
on 10/05/18
31.41 -11.83%
on 10/03/18
-1.98 (-6.66%)
since 09/17/18
3-Month
21.39 +29.48%
on 07/18/18
36.65 -24.43%
on 08/20/18
+6.08 (+28.16%)
since 07/17/18
52-Week
11.65 +137.73%
on 05/04/18
36.65 -24.43%
on 08/20/18
-4.67 (-14.42%)
since 10/17/17

Most Recent Stories

More News
Mallinckrodt To Present At Jefferies London Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, Nov. 14, 2018, at the Jefferies London Healthcare Conference in London.

MNK : 27.67 (-0.57%)
Mallinckrodt's Stratatech Company Awarded $26 Million in Additional BARDA Funding for Pediatric Studies of StrataGraft® Skin Tissue in Thermal Burns

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced that Stratatech, a Mallinckrodt company, was awarded approximately $26 million in additional Project BioShield...

MNK : 27.67 (-0.57%)
Shares of Perrigo Co Plc Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (PRGO , PBH , MNK , COLL , MYL )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

PBH : 39.19 (-0.03%)
MNK : 27.67 (-0.57%)
PRGO : 73.81 (+1.46%)
Generic-Drugs Stock Outlook: No Respite from Pricing Issues

Generic-Drugs Stock Outlook: No Respite from Pricing Issues

MYL : 33.16 (+0.15%)
FIXX : 20.16 (+0.60%)
PGNX : 5.41 (-3.74%)
MNK : 27.67 (-0.57%)
BHC : 24.86 (-4.09%)
EVOK : 2.63 (-0.38%)
U.S. FDA Announces Joint Advisory Committee Review of Mallinckrodt's Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone® (Oxycodone Hydrochloride)

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has confirmed it will hold a joint meeting of its Anesthetic...

MNK : 27.67 (-0.57%)
MNK November 23rd Options Begin Trading

Investors in Mallinckrodt plc saw new options become available today, for the November 23rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MNK options chain...

MNK : 27.67 (-0.57%)
MNK or AMPH: Which Is the Better Value Stock Right Now?

MNK vs. AMPH: Which Stock Is the Better Value Option?

AMPH : 18.88 (+1.34%)
MNK : 27.67 (-0.57%)
Forget Mylan, Invest in These 3 Generic/Drug Stocks Instead

Given the recent spate of setbacks suffered by Mylan (MYL), we suggest investing in better-ranked generic/drug companies with favorable growth profile.

MYL : 33.16 (+0.15%)
ENDP : 16.92 (-7.54%)
MNK : 27.67 (-0.57%)
TEVA : 21.27 (-4.45%)
EVOK : 2.63 (-0.38%)
Dance Biopharm Holdings announces the appointment of Anne Whitaker as Chief Executive Officer

Dance Biopharm Holdings Inc. ("Dance"), a private biotechnology company focused on developing transformational healthcare solutions to treat diabetes and other serious chronic diseases, is pleased to announce...

CREE : 39.70 (+5.75%)
MNK : 27.67 (-0.57%)
Mallinckrodt plc To Report Earnings Results For Third Quarter Of Fiscal 2018

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, announced today that it will report third quarter fiscal 2018 earnings results for the period ending Sept. 28,...

MNK : 27.67 (-0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade MNK with:

Business Summary

Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media...

See More

Key Turning Points

2nd Resistance Point 28.46
1st Resistance Point 28.14
Last Price 27.67
1st Support Level 27.28
2nd Support Level 26.74

See More

52-Week High 36.65
Last Price 27.67
Fibonacci 61.8% 27.10
Fibonacci 50% 24.15
Fibonacci 38.2% 21.20
52-Week Low 11.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar